X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24) 24
cd4 immunoadhesins - therapeutic use (9) 9
hiv (9) 9
index medicus (9) 9
adult (8) 8
animals (8) 8
female (7) 7
hiv infections - drug therapy (7) 7
male (7) 7
medicine, research & experimental (7) 7
anti-hiv agents - therapeutic use (6) 6
cd4 immunoadhesins - adverse effects (6) 6
immunology (6) 6
research (6) 6
cd4 antigens - immunology (5) 5
cd4-positive t-lymphocytes - immunology (5) 5
human immunodeficiency virus--hiv (5) 5
human-immunodeficiency-virus (5) 5
immunodeficiency-virus type-1 (5) 5
immunoglobulins (5) 5
infection (5) 5
lymphocytes (5) 5
aids-related complex (4) 4
antibodies (4) 4
antigens (4) 4
cd4 antigen (4) 4
cd4 t-cells (4) 4
cytokines (4) 4
disease (4) 4
gene therapy (4) 4
health aspects (4) 4
hiv infections - immunology (4) 4
hiv infections - virology (4) 4
infections (4) 4
infectious diseases (4) 4
lymphocytes t (4) 4
mice (4) 4
middle aged (4) 4
monoclonal-antibodies (4) 4
recombinant soluble cd4 (4) 4
review (4) 4
t cells (4) 4
vaccines (4) 4
aids (3) 3
anti-hiv agents - adverse effects (3) 3
antibodies, monoclonal - therapeutic use (3) 3
autoimmune diseases (3) 3
biochemistry & molecular biology (3) 3
biotechnology & applied microbiology (3) 3
cd4 (3) 3
cd4 antigens - genetics (3) 3
cd4 immunoadhesins - administration & dosage (3) 3
disease models, animal (3) 3
double-blind (3) 3
gene expression (3) 3
hiv infection (3) 3
hiv infections - blood (3) 3
hiv-1 - drug effects (3) 3
hiv-1 - immunology (3) 3
immunotherapy (3) 3
inflammation (3) 3
multidisciplinary sciences (3) 3
neutralization (3) 3
pharmacology & pharmacy (3) 3
rheumatoid-arthritis (3) 3
soluble cd4 (3) 3
therapy (3) 3
tumor-necrosis-factor (3) 3
viral load (3) 3
virus diseases (3) 3
viruses (3) 3
zidovudine - adverse effects (3) 3
zidovudine - therapeutic use (3) 3
2',3'-dideoxyinosine ddi (2) 2
acquired immunodeficiency syndrome - drug therapy (2) 2
acquired immunodeficiency syndrome - immunology (2) 2
aids vaccines - genetics (2) 2
analysis (2) 2
anti-hiv agents - pharmacokinetics (2) 2
anti-hiv agents - pharmacology (2) 2
antibodies, monoclonal - adverse effects (2) 2
antibodies, neutralizing - immunology (2) 2
antiretroviral therapy (2) 2
antivirals (2) 2
behcets-disease (2) 2
biological therapy - methods (2) 2
cd4 immunoadhesins - metabolism (2) 2
cd4 immunoadhesins - pharmacology (2) 2
cd4 lymphocyte count (2) 2
cd4+ t cells (2) 2
cd4+t cells (2) 2
cell fusion (2) 2
cell line (2) 2
child (2) 2
clinical trials as topic (2) 2
cytokines - therapeutic use (2) 2
cytotoxicity (2) 2
development and progression (2) 2
drug therapy (2) 2
envelope glycoprotein (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 1996, Volume 34, Issue 2 I, pp. 244 - 252
Journal Article
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, ISSN 1077-9450, 1995, Volume 10, Issue 2, pp. 150 - 156
Journal Article
Journal Article
Journal Article
British Journal of Ophthalmology, ISSN 0007-1161, 11/1999, Volume 83, Issue 11, pp. 1230 - 1234
Journal Article
BMC Immunology, ISSN 1471-2172, 08/2017, Volume 18, Issue 1, pp. 40 - 11
Background: Cancer therapeutic vaccine induced cytotoxic T cell (CTL) responses are pivotal for the killing of tumour cells. Blocking interleukin 10 (IL-10)... 
Inflammation | CD4+ T cells | Intestine | Immunotherapy | Il-10 | THERAPEUTIC VACCINE | ANTIGEN-EXPERIENCED HOST | TUMOR | CERVICAL-CANCER | INTERLEUKIN-10 | IMMUNOLOGY | CD4+T cells | T-CELL RESPONSES | VIRUS-LIKE PARTICLES | HPV VACCINES | INFECTION | BLOCKADE | Cell Proliferation | Spleen - immunology | Papillomavirus E7 Proteins - immunology | Intestines - immunology | Oncogene Proteins, Fusion - immunology | CD4-Positive T-Lymphocytes - immunology | Signal Transduction - immunology | Antibodies - immunology | Female | Interleukin-10 - secretion | Disease Models, Animal | T-Lymphocytes, Cytotoxic - immunology | Immunization - adverse effects | Intestines - pathology | Immunization - methods | Mice, Inbred C57BL | Autoimmune Diseases - immunology | Spleen - cytology | Mice, Inbred NOD - immunology | Mice, Knockout | Animals | CD4-Positive T-Lymphocytes - secretion | Interleukin-10 - antagonists & inhibitors | Papillomavirus E7 Proteins - chemistry | Mice | Oncogene Proteins, Viral - immunology | Interleukin-10 - immunology | Physiological aspects | Immunization | Research | Interleukin-10 | T cells | Health aspects | Animal models | Peptides | Chronic infection | Cytotoxicity | Infections | Lymphocytes T | Vaccines | Experiments | Lymph nodes | Metastases | Cancer vaccines | Ethics | Human papillomavirus | Lymphocytes | Rodents | Spleen | Antigens | Cytomegalovirus | Cytokines | Diabetes mellitus | CD4 antigen | Side effects | Interleukin 10 | Regulation | Diabetes | Autoimmune diseases | Cervical cancer | Tumors | Cancer
Journal Article
Journal Article
Expert Opinion on Biological Therapy, ISSN 1471-2598, 05/2006, Volume 6, Issue 5, pp. 523 - 531
The demand for new treatment options against HIV is becoming increasingly desperate as the side effects and the expansion and spread of drug-resistant virus... 
antibody therapeutics | fusion | vaccine | HIV | neutralisation | envelope glycoprotein | Vaccine | Antibody therapeutics | Neutralisation | Fusion | Envelope glycoprotein